Description
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 20 June 2025, approved serplulimab (Hetronifly) to treat adults with extensive-stage small cell lung cancer (ES-SCLC), which has not previously been treated, and has spread within the lungs or to other parts of the body.
SCLC is a fast-growing cancer that typically develops in the airways of the lungs. It accounts for 10-15% of lung cancer cases and is often diagnosed at a late stage when the cancer has already spread.
Serplulimab is a monoclonal antibody (a targeted therapy) that supports the immune system by blocking PD-1, a receptor some cancer cells use to avoid detection. By inhibiting PD-1, it helps immune cells recognise and destroy cancer cells more effectively.
Serplulimab is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “HETRONIFLY (Serplulimab) Injection in India“, patients can simply fill the order form or, please call us at 9811747774, 9555306364 or WhatsApp at 9555306364, 9555306364 or email us at info@lucknowpharma.com. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
NEWS / UPDATES
- Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer.
- [European Medicines Agency (EMA). Medicines. Hetronifly. [cited 2024-11-18]. Available from:
https://www.ema.europa.eu/en/medicines/human/EPAR/hetronifly. - Statistik Austria. Krebserkrankungen. Krebsinzidenz nach ausgewählten Lokalisationen und Geschlecht. [cited 2024-11-18]. Available from:
https://www.statistik.at/statistiken/bevoelkerung-und-soziales/gesundheit/krebserkrankungen. - Onkopedia, Wolf M and et al. Onkopedia guidelines. Small-Cell Lung Cancer (SCLC). [cited 2024-11-18]. Available from: https://www.onkopediaguidelines.info/en/onkopedia/guidelines/small-cell-lung-cancer-sclc/@@guideline/html/index.html#ID0E5DBG.
- U.S. Food and Drug Administration (FDA). Orphan Drug Designations and Approvals. [cited 2024-11-18]. Available from:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=869822.





